Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
CRDF
$1.10
+3.30%
CRDF
· Cardiff Oncology, Inc.
$1.10
+0.04 (+3.30%)
At close · Oct 9
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has performed an analysis and concluded that there exists a substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$82.85M
Shares
77.80M
Volume · Oct 9
80.23K
Avg daily vol (3M)
1.05M
All webcasts
Earnings call · FY2022 Q4
Cardiff Oncology, Inc. (CRDF) Q4 2022 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$128,000
-3.8% YoY
Net income · derived Q4
-$8.70M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 2, 2023 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 2, 2023 · complete as-filed document